Chapter 5. GABA Agonists and Antagonists

1979, Huntington's Disease, 23 Hornykiewicz, 1976, 479 Lloyd, 1979, GABA-Biochemistry and CNS Functions, 123, 399 Naftchi, 1979, GABA-Biochemistry and CNS Functions, 123, 431 Meldrum, 1975, Int. Rev. Neurobiol., 17, 1, 10.1016/S0074-7742(08)60205-6 Meldrum, 1979, 390 Roberts, 1974, Biochem. Pharmacol., 23, 2637, 10.1016/0006-2952(74)90033-1 Van Kammen, 1977, Am. J. Psychiatry, 134, 138, 10.1176/ajp.134.2.138 Perry, 1979, Lancet, i, 237, 10.1016/S0140-6736(79)90767-0 1976 1978 1979 1979, GABA-Biochemistry and CNS Functions, 123 Sytinsky, 1978, Prog. Neurobiol. (Oxford), 10, 89, 10.1016/0301-0082(78)90009-6 Enna, 1979, Life Sci., 24, 1727, 10.1016/0024-3205(79)90060-2 Johnston, 1978, Annu. Rev. Pharmacol., 28, 269, 10.1146/annurev.pa.18.040178.001413 Andrews, 1979, Biochem. Pharmacol., 18, 2697, 10.1016/0006-2952(79)90549-5 Metcalf, 1979, Biochem. Pharmacol., 28, 1705, 10.1016/0006-2952(79)90529-X Nistry, 1979, Prog. Neurobiol. (Oxford), 13, 117, 10.1016/0301-0082(79)90016-9 DeFeudis, 1977, Prog. Neurobiol. (Oxford), 9, 123, 10.1016/0301-0082(77)90015-6 Lester, 1979, Brain Res., 161, 79, 10.1016/0006-8993(79)90197-5 Curtis, 1978, 55 Krnjević, 1979, GABA-Biochemistry and CNS Functions, 123, 271 Enna, 1975, Brain Res., 100, 81, 10.1016/0006-8993(75)90243-7 Snyder, 1976, Annu. Rev. Physiol., 38, 153, 10.1146/annurev.ph.38.030176.001101 Horng, 1979, J. Neurochem., 32, 1379, 10.1111/j.1471-4159.1979.tb11075.x Enna, 1977, Mol. Pharmacol., 13, 442 Krogsgaard-Larsen, 1979, J. Neurochem., 32, 1717, 10.1111/j.1471-4159.1979.tb02284.x Guidotti, 1978, Nature (London), 275, 553, 10.1038/275553a0 Toffano, 1978, Proc. Natl. Acad. Sci. USA, 75, 4024, 10.1073/pnas.75.8.4024 Johnston, 1978, 507 Greenlee, 1978, Life Sci., 22, 1653, 10.1016/0024-3205(78)90062-0 Enna, 1979, 191 Gavish, 1979, Life Sci., 25, 783, 10.1016/0024-3205(79)90523-X Greenlee, 1979, Biochem. Biophys. Res. Commun., 88, 380, 10.1016/0006-291X(79)92059-X Chude, 1979, J. Neurochem., 33, 621, 10.1111/j.1471-4159.1979.tb05206.x Snodgrass, 1978, Nature (London), 274, 392, 10.1038/273392a0 Mitchell, 1978, Nature (London), 274, 904, 10.1038/274904a0 Brennan, 1979, Nature (London), 280, 514, 10.1038/280514a0 Curtis, 1974, Brain Res., 70, 493, 10.1016/0006-8993(74)90257-1 Bowery, 1980, Nature (London), 283, 92, 10.1038/283092a0 Waddington, 1979, Neurosci. Lett., 14, 123, 10.1016/0304-3940(79)95357-6 Johnston, 1975, J. Neurochem., 24, 157, 10.1111/j.1471-4159.1975.tb07642.x Krogsgaard-Larsen, 1975, J. Neurochem., 25, 803, 10.1111/j.1471-4159.1975.tb04411.x Krogsgaard-Larsen, 1978, 305 Curtis, 1974, Ergeb. Physiol. Biol. Chem. Exp. Pharmakol., 69, 97 Beaumont, 1978, Brain Res., 148, 153, 10.1016/0006-8993(78)90385-2 Wang, 1979, Biochem. Pharmacol., 28, 1123, 10.1016/0006-2952(79)90316-2 P. Krogsgaard-Larsen andJ. Arnt, in ‘Proceedings of the International Symposium on GABA and Other Inhibitory Transmitters,’ H. Lal andS. Fielding, Eds., Myrtle Beach, South Carolina, 6–11. November 1979, in press. Krogsgaard-Larsen, 1979, 201 Krogsgaard-Larsen, 1979, GABA-Biochemistry and CNS Functions, 123, 303 Curtis, 1971, Brain Res., 32, 69, 10.1016/0006-8993(71)90156-9 Johnston, 1978, J. Neurochem., 31, 1519, 10.1111/j.1471-4159.1978.tb06579.x Schousboe, 1979, J. Neurochem., 33, 181, 10.1111/j.1471-4159.1979.tb11720.x Atkinson, 1979, J. Med. Chem., 22, 99, 10.1021/jm00187a022 Evans, 1978, J. Pharm. Pharmacol., 30, 364, 10.1111/j.2042-7158.1978.tb13257.x Myers, 1975, 2, 1 Baraldi, 1979, Neuropharmaeology, 18, 57, 10.1016/0028-3908(79)90009-1 Honoré, 1973, Acta Crystallogr., B34, 3417 Krogsgaard-Larsen, 1977, Nature (London), 268, 53, 10.1038/268053a0 Krogsgaard-Larsen, 1973, J. Neurochem., 30, 1377, 10.1111/j.1471-4159.1978.tb10469.x Krogsgaard-Larsen, 1975, J. Neurochem., 25, 797, 10.1111/j.1471-4159.1975.tb04410.x Krogsgaard-Larsen, 1979, Eur. J. Med. Chem. Chim. Ther., 14, 157 Arnt, 1979, Brain Res., 177, 395, 10.1016/0006-8993(79)90793-5 P. Krogsgaard-Larsen, E. Falch, A. Schousboe, D.R. Curtis andD. Lodge, J. Neurochem., 34, 1980, in press. Johnston, 1979, 149 Johnston, 1973, 2, 11 1975, 14 Haefely, 1979, 357 Curtis, 1976, Brain Res., 118, 344, 10.1016/0006-8993(76)90723-X Martin, 1978, Neuropharmacology, 17, 993, 10.1016/0028-3908(78)90145-4 Tallman, 1978, Nature (London), 274, 383, 10.1038/274383a0 Maurer, 1973, Neurosci. Lett., 12, 65, 10.1016/0304-3940(79)91481-2 Karobath, 1979, Nature (London), 278, 748, 10.1038/278748a0 Braestrup, 1979, Nature (London), 280, 331, 10.1038/280331a0 Scheel-Krüger, 1977, Neurosci. Lett., 4, 351, 10.1016/0304-3940(77)90183-5 Olpe, 1977, Eur. J. Pharmacol., 45, 291, 10.1016/0014-2999(77)90012-7 Olianas, 1973, Eur. J. Pharmacol., 49, 233, 10.1016/0014-2999(78)90098-5 Dray, 1976, J. Pharm. Pharmacol., 28, 400, 10.1111/j.2042-7158.1976.tb04187.x Arnt, 1979, Psychopharmacology, 62, 267, 10.1007/BF00431958 Arnt, 1979, J. Pharm. Pharmacol., 31, 306, 10.1111/j.2042-7158.1979.tb13506.x Delini-Stula, 1979, 482 Lloyd, 1979, 308 Bartholini, 1979, 326 E. Falch andP. Krogsgaard-Larsen, in ‘Receptors for Neurotransmitters and Peptide Hormones,’ M. Kuhar, S.J. Enna andG. Pepeu, Eds., Raven Press, New York, 1980, in press. Curtis, 1979, J. Physiol. (London), 219, 19, 10.1113/jphysiol.1979.sp012796 Anlezark, 1977, Neurosci. Lett., 7, 337, 10.1016/0304-3940(78)90223-9 Frey, 1979, Neuropharmacology, 18, 581, 10.1016/0028-3908(79)90108-4 Naik, 1976, Neuropharmacology, 15, 479, 10.1016/0028-3908(76)90058-7 Worms, 1979, Life Sci., 25, 607, 10.1016/0024-3205(79)90555-1 Ho, 1976, Life Sci., 18, 1111, 10.1016/0024-3205(76)90146-6 Kääriäinen, 1976, Acta Pharmacol. Toxicol., 39, 536, 10.1111/j.1600-0773.1976.tb03203.x Yoneda, 1976, Biochem. Pharmacol., 25, 2669, 10.1016/0006-2952(76)90525-6 Biggio, 1977, Neuropharmacology, 16, 149, 10.1016/0028-3908(77)90063-6 Christensen, 1978, Eur. J. Pharmacol., 48, 459, 10.1016/0014-2999(78)90176-0 Antonaccio, 1978, Neuropharmacology, 17, 597, 10.1016/0028-3908(78)90154-5 Antonaccio, 1978, Neuropharmacology, 17, 783, 10.1016/0028-3908(78)90065-5 Sweet, 1979, Can. J. Physiol. Pharmacol., 57, 600, 10.1139/y79-092 DiMicco, 1979, Science, 204, 1106, 10.1126/science.451556 Fujiwara, 1975, Br. J. Pharmacol., 55, 561, 10.1111/j.1476-5381.1975.tb07434.x Edvinsson, 1979, Brain Res., 173, 89, 10.1016/0006-8993(79)91098-9 Christensen, 1976, Psychopharmacology, 48, 1, 10.1007/BF00423298 Petersen, 1972, Acta Pharmacol. Toxicol., 31, 488, 10.1111/j.1600-0773.1972.tb03612.x Scheel-Kruger, 1978, Life Sci., 22, 75, 10.1016/0024-3205(78)90414-9 Arnt, 1979, J. Pharm. Pharmacol., 31, 56, 10.1111/j.2042-7158.1979.tb13427.x Ridley, 1979, Psychopharmacology, 64, 197, 10.1007/BF00496062 Christensen, 1979, Life Sci., 23, 1395, 10.1016/0024-3205(79)90010-9 Cools, 1979, Life Sci., 25, 2475 Garau, 1978, Life Sci., 23, 1745, 10.1016/0024-3205(78)90102-9 Fuxe, 1979, 74 Scheel-Krüger, 1977, Eur. J. Pharmacol., 42, 311, 10.1016/0014-2999(77)90300-4 Shoulson, 1978, Ann. Neurol., 4, 279, 10.1002/ana.410040316 Taminga, 1973, Am. J. Psychiatry, 135, 746 Johnston, 1976, 395 Möhler, 1977, Nature (London), 267, 65, 10.1038/267065a0 Möhler, 1978, Mol. Pharmacol., 14, 256 Olsen, 1978, 467 Johnston, 1972, Nature (London) New Biol., 240, 219, 10.1038/240219a0 Möhler, 1979, GABA-Biochemistry and CNS Functions, 123, 355 Olsen, 1979, 165 Hill, 1976, Br. J. Pharmacol., 56, 9, 10.1111/j.1476-5381.1976.tb06952.x Enna, 1977, Brain Res., 124, 185, 10.1016/0006-8993(77)90878-2 Bowery, 1979, GABA-Biochemistry and CNS Functions, 123, 339